IMXI vs SRPT · P/E 6.4, rev $253.1M vs rev $1.13B
International Money Express Inc (IMXI) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
International Money Express Inc (IMXI) is a software - infrastructure company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported IMXI revenue for 2026-06-30 was $253.1M. Net income was $4.7M. IMXI currently screens at market cap $324.6M and trailing P/E 6.4.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
IMXI currently screens at market cap $324.6M and trailing P/E 6.4. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the IMXI and SRPT stock pages for the full models.
Not investment advice.